Results 131 to 140 of about 119,934 (290)
Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that's usually detected at an advanced stage and has a high recurrence rate despite surgical resection, making treatment challenging. Although mitotane is still the only approved treatment, its poor effectiveness has raised interest in immunotherapy with immune checkpoint inhibitors (ICIs ...
Jawairya Muhammad Hussain+5 more
wiley +1 more source
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is approved in the US for the treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed IV edaravone slows the rate of physical functional decline.
Jeffrey Rothstein+17 more
wiley +1 more source
Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms [PDF]
Background: Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a ...
Dinh, Q. Thai+6 more
core
The Investigation and Treatment of Anogenital Pruritus [PDF]
Brian Russell
openalex +1 more source
Urticarial Plaques With Vesicles in a Young Hispanic Woman
JEADV Clinical Practice, EarlyView.
Valeria Olvera‐Rodríguez+6 more
wiley +1 more source
FLASH‐RT has been shown to protect normal tissues, the clinical translation of FLASH‐RT is ongoing. We designed a phase I clinical trial to estimate the safety and healthy tissue spare by using a modified clinical linear accelerator Abstract Objective Ultra‐high dose rate FLASH radiotherapy (FLASH‐RT) is emerging as a novel technique to improve the ...
Chengliang Yang+11 more
wiley +1 more source
The Role of Proteolytic Enzymes in the Production of Pruritus in Man*
Robert P. Arthur, Walter B. Shelley
openalex +1 more source
Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients [PDF]
Saeid Amirkhanlou+4 more
openalex +1 more source
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño+4 more
wiley +1 more source